doxepin has been researched along with Hypersensitivity in 2 studies
Doxepin: A dibenzoxepin tricyclic compound. It displays a range of pharmacological actions including maintaining adrenergic innervation. Its mechanism of action is not fully understood, but it appears to block reuptake of monoaminergic neurotransmitters into presynaptic terminals. It also possesses anticholinergic activity and modulates antagonism of histamine H(1)- and H(2)-receptors.
doxepin : A dibenzooxepine that is 6,11-dihydrodibenzo[b,e]oxepine substituted by a 3-(dimethylamino)propylidene group at position 11. It is used as an antidepressant drug.
Hypersensitivity: Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kanba, S | 1 |
Richelson, E | 1 |
Shelanski, MV | 1 |
Phillips, SB | 1 |
Potts, CE | 1 |
1 trial available for doxepin and Hypersensitivity
Article | Year |
---|---|
Evaluation of cutaneous reactivity to recently marketed dermatologic products.
Topics: Adult; Aged; Aged, 80 and over; Allergens; Antifungal Agents; Calcitriol; Clobetasol; Dermatitis, Ir | 1996 |
1 other study available for doxepin and Hypersensitivity
Article | Year |
---|---|
Pharmacological properties of tricyclic antidepressants and the treatment of somatic disorders.
Topics: Antidepressive Agents, Tricyclic; Doxepin; Gastrointestinal Diseases; Histamine H2 Antagonists; Huma | 1984 |